Como, Italy

Giancarlo Farolfi


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1990-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Giancarlo Farolfi: Innovator in Pharmaceutical Compositions

Introduction

Giancarlo Farolfi is a notable inventor based in Como, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable aqueous suspensions and innovative therapeutic compositions. With a total of two patents to his name, Farolfi's work has the potential to enhance treatment options for various medical conditions.

Latest Patents

Farolfi's latest patents include "Stable aqueous suspensions of mesalazine" and "Pharmaceutical composition for the prophylaxis and therapy of gastric." The first patent discloses new compositions of mesalazine in the form of aqueous suspensions, characterized by their increased stability compared to prior art. These compositions incorporate colloidal cellulose and one or more hydrophilic thickening agents. The second patent presents a combination of a hydrophilic polymer with sulglycotide in pharmaceutical compositions for oral use, which enhances the anti-ulcer activity of sulglycotide.

Career Highlights

Giancarlo Farolfi is associated with Crinos Industria Farmacobiologica S.p.a., where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug formulations to provide better therapeutic outcomes for patients.

Collaborations

Farolfi collaborates with esteemed colleagues such as Franco Lattuada and Laura Ferro, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.

Conclusion

Giancarlo Farolfi's contributions to pharmaceutical inventions demonstrate his commitment to advancing medical treatments. His patents reflect a deep understanding of drug formulation and stability, which can significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…